Our results suggest that adequate classification of the major and clinically relevant molecular subtypes of breast cancer can be robustly achieved with quantitative measurements of three key genes.
2012-02-22
Eng.
Journal of the National Cancer Institute
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. bhaibeka [at] jimmy.harvard.edu
J Natl Cancer Inst. 2012 Feb;104(4):311-25
© Galenicom 1999-2013